Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Completed1
Recruiting1
Other2

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT05322330Phase 2Completed
Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
StudychairStart date: 2022-02-10
NCT04835870Phase 2Unknown
Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
Non-GCB/ABC Diffuse Large B-Cell Lymphoma
StudychairStart date: 2021-04-01
NCT05182957Phase 2Recruiting
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
Relapsed/Refractory Peripheral T-cell Lymphoma
StudychairStart date: 2020-01-01
NCT05312476Phase 2Withdrawn
Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05322330Phase 2StudyChair

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Completed
NCT04835870Phase 2StudyChair

Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Non-GCB/ABC Diffuse Large B-Cell Lymphoma
Unknown
NCT05182957Phase 2StudyChair

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

Relapsed/Refractory Peripheral T-cell Lymphoma
Recruiting
NCT05312476Phase 2StudyChair

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Withdrawn

All 4 trials loaded